[144] Sight Sciences, Inc. SEC Filing

Rhea-AI Filing Summary

Sight Sciences (SGHT) Form 144: An insider notified the SEC of a proposed sale of 15,990 common shares acquired via restricted stock vesting on 10/15/2024. The filing lists the broker as Fidelity Brokerage Services LLC and an approximate aggregate market value of $55,291.81 with an anticipated sale date of 09/16/2025 on NASDAQ. The filing also discloses two recent sales by the same person: 4,889 shares sold on 07/02/2025 for $20,036.59 and 10,000 shares sold on 09/12/2025 for $35,227.21. The shares to be sold were paid as compensation when vested and the filer attests they have no undisclosed material adverse information.

Positive

• Full disclosure of the source of shares (restricted stock vesting) and broker details (Fidelity Brokerage Services LLC).
• Recent sale history is provided, offering transparency on prior dispositions (4,889 and 10,000 shares).
• Filer attestation that no undisclosed material adverse information is known.

Negative

• Insider sales were executed recently (7/02/2025 and 9/12/2025), which some investors may view negatively even though amounts are small.
• Filing does not state any adoption date for a Rule 10b5-1 trading plan, so trading-plan protection is not documented in this notice.

Insights

Securities Analyst

TL;DR: Insider plans to sell vested restricted shares totaling 15,990 shares (about $55k); recent sales show prior disposals of the same holder.

The Form 144 shows a routine, disclosed sale by an insider where the underlying shares were acquired via restricted stock vesting and paid as compensation. The proposed sale amount (~$55k) is immaterial relative to the issuer's 52,367,359 outstanding shares, indicating limited potential market impact. The filing properly identifies the executing broker and planned timing, and includes recent sale activity (4,889 and 10,000 shares) which provides context on the seller's recent liquidity actions.

Corporate Governance Specialist

TL;DR: This is a compliance-focused disclosure of insider sales; transactions appear consistent with compensation vesting and post-vesting disposition.

The disclosure confirms the shares originate from a 10/15/2024 restricted stock vesting, which supports routine post-vesting sale rather than an opportunistic sale of previously owned unrestricted shares. The seller’s attestation about lack of undisclosed material information aligns with Form 144 requirements. From a governance perspective, the filing is complete in the elements shown, but does not include any trading-plan adoption dates that would indicate Rule 10b5-1 reliance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	15990	55291.81	52367359	09/16/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/15/2024	Restricted Stock Vesting	Issuer			15990	10/15/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Matthew Link 4040 Campbell Ave Suite 100 Menlo Park CA 94025	Common	07/02/2025	4889	20036.59
Matthew Link 4040 Campbell Ave Suite 100 Menlo Park CA 94025	Common	09/12/2025	10000	35227.21

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the SGHT Form 144 disclose about the shares to be sold?

The filing discloses a proposed sale of 15,990 common shares acquired via restricted stock vesting on 10/15/2024, with an aggregate market value of $55,291.81 and an approximate sale date of 09/16/2025 on NASDAQ.

Who is the broker handling the proposed SGHT sale?

The broker listed is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI.

Has the filer recently sold other SGHT shares?

Yes. The filing reports two recent sales by the same person: 4,889 shares sold on 07/02/2025 for $20,036.59 and 10,000 shares sold on 09/12/2025 for $35,227.21.

How were the shares acquired according to the filing?

The shares to be sold were acquired through restricted stock vesting and payment was recorded as compensation on 10/15/2024.

Does the filing state whether a 10b5-1 trading plan was used?

The filing does not provide a date of adoption for a Rule 10b5-1 trading plan and does not indicate reliance on such a plan.